Perspective Therapeutics, Inc.
CATX· NYSE
CATXPerspective Therapeutics, Inc.
Filed Feb 14, 2013 · 10-Q · 45 days after period end · 0001144204-13-008537
| Metric | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|
| Revenue | $975.46K | $1.23M | $1.24M |
| Net Income | -$1.15M | -$628.75K | -$228.07K |
| EPS Diluted | -$0.03 | -$0.02 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Perspective Therapeutics, Inc. · CIK 728387 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Feb 14, 2013 · 45 d after period end
